Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.3.0.814
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenue $ 37,733 $ 26,877 $ 85,308 $ 49,344
Cost of sales 25,547 18,318 56,879 33,316
Gross profit 12,186 8,559 28,429 16,028
Selling, general and administrative:        
Acquisition, severance and transition costs 718 272 1,470 938
Amortization and depreciation 1,213 1,750 3,391 3,858
Stock-based compensation 919 227 2,082 588
Other selling, general and administrative 8,429 6,560 22,641 16,562
Research and development 733 495 1,639 1,474
Total operating expenses 12,012 9,304 31,223 23,420
Operating income (loss) 174 (745) (2,794) (7,392)
Other expense:        
Interest expense and other bank charges (459) (163) (1,025) (640)
Loss before taxes (285) (908) (3,819) (8,032)
Deferred income tax (provision) benefit   (496)   5,468
Net loss (285) (1,404) (3,819) (2,564)
Accrual of preferred stock dividends   (645)   (1,449)
Accretion to redemption value of Series E, F and G preferred stock   (6)   (919)
Net loss attributable to common stockholders $ (285) $ (2,055) $ (3,819) $ (4,932)
Net loss per common share attributable to common stockholders - Basic and Diluted $ 0.00 $ (0.02) $ (0.03) $ (0.06)
Weighted average shares outstanding - Basic and Diluted 154,634 90,714 145,414 87,179